Only third of convalescent plasma suitable for Covid-19 treatment
Ljubljana, 3 March - Only a third of plasma taken by the Blood Transfusion Centre from those who recovered from Covid-19 contains sufficient amounts of neutralising antibodies to be used as treatment for Covid-19, while 12% of those who recovered did not even develop antibodies.
The rest of this news item is available to subscribers.
The news item consists of 1.406 characters (without spaces) or 264 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.